307 related articles for article (PubMed ID: 28545521)
21. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.
Klaasen HL; Molkenboer MJ; Vrijenhoek MP; Kaashoek MJ
Vet Microbiol; 2003 Aug; 95(1-2):121-32. PubMed ID: 12860082
[TBL] [Abstract][Full Text] [Related]
22. A serological survey of leptospiral antibodies in dogs in New Zealand.
Harland AL; Cave NJ; Jones BR; Benschop J; Donald JJ; Midwinter AC; Squires RA; Collins-Emerson JM
N Z Vet J; 2013 Mar; 61(2):98-106. PubMed ID: 23013160
[TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of leptospirosis in an endemic mixed urban and semi-urban setting-A community-based study in the district of Colombo, Sri Lanka.
Rajapakse S; Weeratunga PN; Balaji K; Ramchandani KC; de Silva US; Ranasinghe SA; Gunarathne D; Wijerathne PPB; Fernando N; Handunnetti SM; Fernando SD
PLoS Negl Trop Dis; 2020 May; 14(5):e0008309. PubMed ID: 32428003
[TBL] [Abstract][Full Text] [Related]
24. Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars.
Wilson S; Stirling C; Thomas A; King V; Plevová E; Chromá L; Siedek E; Illambas J; Salt J; Sture G
Vaccine; 2013 Jun; 31(31):3126-30. PubMed ID: 23707443
[TBL] [Abstract][Full Text] [Related]
25. Vaccine-associated Leptospira antibodies in client-owned dogs.
Martin LE; Wiggans KT; Wennogle SA; Curtis K; Chandrashekar R; Lappin MR
J Vet Intern Med; 2014; 28(3):789-92. PubMed ID: 24597674
[TBL] [Abstract][Full Text] [Related]
26. Identification of the most effective serovars to be included in the MAT antigen panel to optimize the serodiagnosis of Leptospira infection in Northern Italy.
Balboni A; D'Incau M; Zamagni S; Lucchese L; Mazzotta E; Marchione S; Battilani M; Natale A
Vet Res Commun; 2023 Dec; 47(4):2185-2192. PubMed ID: 36929155
[TBL] [Abstract][Full Text] [Related]
27. A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.
Bouvet J; Lemaitre L; Cariou C; Scotto M; Blain C; Oberli F; Cupillard L; Guigal PM
Vet Immunol Immunopathol; 2020 Jan; 219():109985. PubMed ID: 31759261
[TBL] [Abstract][Full Text] [Related]
28. Leptospira infection and shedding in dogs in Thailand.
Altheimer K; Jongwattanapisan P; Luengyosluechakul S; Pusoonthornthum R; Prapasarakul N; Kurilung A; Broens EM; Wagenaar JA; Goris MGA; Ahmed AA; Pantchev N; Reese S; Hartmann K
BMC Vet Res; 2020 Mar; 16(1):89. PubMed ID: 32178664
[TBL] [Abstract][Full Text] [Related]
29. Canine leptospirosis--do we have a problem?
André-Fontaine G
Vet Microbiol; 2006 Oct; 117(1):19-24. PubMed ID: 16684591
[TBL] [Abstract][Full Text] [Related]
30. Serological evidence of exposure of healthy dogs to Leptospira in Sydney, New South Wales, Australia.
Griebsch C; Kirkwood N; Ward MP; Norris JM
Aust Vet J; 2024 Apr; 102(4):215-221. PubMed ID: 38220214
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibodies to Leptospira serovars in rodents and shrews trapped in low and high endemic areas in Thailand.
Kositanont U; Naigowit P; Imvithaya A; Singchai C; Puthavathana P
J Med Assoc Thai; 2003 Feb; 86(2):136-42. PubMed ID: 12678151
[TBL] [Abstract][Full Text] [Related]
32. Detection of Leptospira DNA in urine and presence of specific antibodies in outdoor cats in Germany.
Weis S; Rettinger A; Bergmann M; Llewellyn JR; Pantchev N; Straubinger RK; Hartmann K
J Feline Med Surg; 2017 Apr; 19(4):470-476. PubMed ID: 26927819
[TBL] [Abstract][Full Text] [Related]
33. A novel octavalent combined Erysipelas, Parvo and Leptospira vaccine provides (cross) protection against infection following challenge of pigs with 9 different
Jacobs A; Harks F; Hoeijmakers M; Segers R
Porcine Health Manag; 2015; 1():16. PubMed ID: 28405422
[TBL] [Abstract][Full Text] [Related]
34. A review of leptospirosis in farm animals in Portugal.
Rocha T
Rev Sci Tech; 1998 Dec; 17(3):699-712. PubMed ID: 9850541
[TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies against Leptospira serovars via microscopic agglutination tests in dogs in the United States, 2000-2007.
Gautam R; Wu CC; Guptill LF; Potter A; Moore GE
J Am Vet Med Assoc; 2010 Aug; 237(3):293-8. PubMed ID: 20673110
[TBL] [Abstract][Full Text] [Related]
36. Control of canine leptospirosis in Europe: time for a change?
Ellis WA
Vet Rec; 2010 Oct; 167(16):602-5. PubMed ID: 21257439
[TBL] [Abstract][Full Text] [Related]
37. MAT cross-reactions or vaccine cross-protection: retrospective study of 863 leptospirosis canine cases.
André-Fontaine G; Triger L
Heliyon; 2018 Nov; 4(11):e00869. PubMed ID: 30426097
[TBL] [Abstract][Full Text] [Related]
38. Seroepidemiology of canine leptospirosis on the island of Barbados.
Weekes CC; Everard CO; Levett PN
Vet Microbiol; 1997 Sep; 57(2-3):215-22. PubMed ID: 9355256
[TBL] [Abstract][Full Text] [Related]
39. An Assessment and Comparison of the Efficacy of Two Licensed Tetravalent Leptospira Vaccines for Dogs Using an Improved Challenge Model.
Klaasen HLBM; Veen MV; Dorrestein-Spierenburg CM; Cao Q
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146551
[TBL] [Abstract][Full Text] [Related]
40. Emerging leptospirosis in urban Sydney dogs: a case series (2017-2020).
Griebsch C; Kirkwood N; Ward MP; So W; Weerakoon L; Donahoe S; Norris JM
Aust Vet J; 2022 May; 100(5):190-200. PubMed ID: 35076093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
